DVAX News and Press, Dynavax Technologies Corporation

Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program PR Newswire EMERYVILLE, Calif. , June 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing inn...

2024-06-21 02:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-11 12:40:57 ET Dynavax Technologies ( DVAX ), Bloomin Brands ( BLMN ), and Premier Inc. ( PINC ) have tied to be the most shorted small-cap stocks in May, according to a monthly report issued Tuesday by data and tech firm Hazeltree.... Read the full articl...

2024-06-03 10:45:05 ET Sunnova Energy International Inc (NOVA) NOVA is trading UP for the last 5 days, and it at trading at $5.90 with volume of 3,907,455 and a one day change of $0.68 (12.93%). Sunnova Energy International Inc has a 52-week low of 3.37 and a 52-week high of $24.56....

2024-05-30 11:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-14 08:59:26 ET More on Dynavax Dynavax: HEPLISAV-B Growth Up, Pipeline Uncertain Dynavax Technologies Corporation (DVAX) Q1 2024 Earnings Call Transcript Dynavax Technologies: Still A Believer Dynavax drops 6% as quarterly results miss on both lines ...

Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S. PR Newswire EMERYVILLE, Calif. , May 14, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) today provided a regula...

2024-05-10 09:02:13 ET Summary HEPLISAV-B Q1 revenue was $48 million, showing 10% YoY growth. Dynavax's shingles and Tdap vaccines advanced in clinical stages, with data anticipated in the coming quarters. Dynavax's balance sheet remains robust with a significant cash runway. ...

2024-05-09 02:15:16 ET Image source: The Motley Fool. Dynavax Technologies (NASDAQ: DVAX) Q1 2024 Earnings Call May 08, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Dynavax Technologies (DVAX) Q1 2024 Earnings Call Tr...

2024-05-08 19:51:09 ET Dynavax Technologies Corporation (DVAX) Q1 2024 Earnings Conference Call May 08, 2024, 16:30 ET Company Participants Paul Cox - VP, Investor Relations & Corporate Communications Ryan Spencer - CEO Donn Casale - Chief Commercial Officer ...